News & Updates
Filter by Specialty:
Upadacitinib works in select ankylosing spondylitis patients
The Janus kinase inhibitor upadacitinib induces significantly higher response than placebo in ankylosing spondylitis patients with inadequate response to biological disease-modifying antirheumatic drugs, without introducing new safety signals, according to data from a phase III trial.
Upadacitinib works in select ankylosing spondylitis patients
14 Jul 2022
Skipping breakfast protects against age-related macular degeneration
Older people who intermittently fast by skipping breakfast appear to have a reduced risk of age-related macular degeneration, a study has found.
Skipping breakfast protects against age-related macular degeneration
14 Jul 2022
Venetoclax-obinutuzumab ± ibrutinib induces PFS benefit in CLL
A time-limited regimen of venetoclax plus obinutuzumab with or without ibrutinib improved progression-free survival (PFS) in fit, treatment-naïve patients with chronic lymphocytic leukaemia (CLL), according to results of the phase III GAIA/CLL13 trial presented at EHA 2022.
Venetoclax-obinutuzumab ± ibrutinib induces PFS benefit in CLL
13 Jul 2022
Low vitamin D tied to lower risk of radiologic osteoarthritis in older men
A recent Korea study has found that low levels of vitamin D appear to be significantly protective against radiologic osteoarthritis (ROA) in older men but not women.
Low vitamin D tied to lower risk of radiologic osteoarthritis in older men
13 Jul 2022
Anaemia a major indication for obstetric red cell transfusion in multiethnic population
Red cell transfusion at a high-volume tertiary hospital in Singapore has an incidence of 3.2 percent in a multiethnic obstetric population, according to a study. Anaemia during pregnancy is the most common reason for transfusion administration.
Anaemia a major indication for obstetric red cell transfusion in multiethnic population
13 Jul 2022
Keto or Mediterranean diet for diabetes: Do we have a clear winner?
The ketogenic (keto) diet appears as good as the Mediterranean diet in reducing blood sugar in individuals with prediabetes, or type 2 diabetes (T2D), according to a small, randomized, crossover trial.
Keto or Mediterranean diet for diabetes: Do we have a clear winner?
13 Jul 2022
Dextromethorphan-bupropion relieves symptoms in major depressive disorder
Treatment with dextromethorphan-bupropion (AXS-05) significantly improves depressive symptoms relative to bupropion alone and is well tolerated in patients with major depression, results of a phase II trial have shown.